Melissa Burgess, MD
Medical Oncology · Pittsburgh, PANPI 1497982649
Payments from drug & device makers
Across 486 payments — averaging $4888.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$623K
- Incyte Corporation$341K
- Merck$333K
- Eli Lilly$301K
- PTC Therapeutics, Inc.$235K
- Deciphera Pharmaceuticals Inc.$147K
- plus $397K from 9 others
Across 1 payment — averaging $17,924 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$18K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 94 | $622,538 |
| Incyte Corporation | 222 | $341,162 |
| Merck | 4 | $332,620 |
| Eli Lilly | 9 | $300,714 |
| PTC Therapeutics, Inc. | 24 | $234,540 |
| Deciphera Pharmaceuticals Inc. | 3 | $146,788 |
| Karyopharm Therapeutics Inc. | 9 | $107,604 |
| EMD Serono, Inc. | 49 | $99,726 |
| Epizyme, Inc. | 17 | $57,379 |
| Ares Trading SA | 23 | $50,142 |
| Trillium Therapeutics USA, LLC | 7 | $31,404 |
| Blueprint Medicines Corporation | 8 | $25,350 |
| Adaptimmune LLC | 13 | $23,880 |
| Springworks Therapeutics, Inc. | 2 | $1,604 |
| Aadi Bioscience, Inc. | 2 | $233 |
How this compares
$2,375,684 in reported general payments places this provider in the 85th percentile of 238 medical oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Pittsburgh
- Adam BrufskyPittsburgh$6M
- John KirkwoodPittsburgh$3.4M
- Nathan BaharyPittsburgh$2.1M
- Jane RaymondPittsburgh$794K
- Ariel Lopez-ChavezPittsburgh$727K
- Ashwin SomasundaramPittsburgh$696K
- Sukhmani PaddaPhiladelphia$25.6M
- Peter O DwyerPhiladelphia$18M
- Margaret von MehrenPhiladelphia$17.4M
- Kim Reiss BinderPhiladelphia$16.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.